Following Canopy Growth’s announcement of its 72% stake in BioSteel Sports Nutrition, Canaccord Genuity analyst Matt Bottomley believes BioSteel can be a great addition to Canopy’s development strategy.
BioSteel Sports Nutrition products are present in more than 10,000 shops in North America and are linked to prestigious sportsmen and women.
CBD products are becoming more and more popular with athletes of all levels.
The Canaccord analyst recommends Canopy Growth as a “speculative purchase” with a target price of $ 60.
To be up to date with the most impactful news on Canopy Growth follow our Newsletters for free
This article is written and published by The Cannabis Stock
Disclaimer : The Cannabis Stock wants to promote the cannabis market with the best publication on the market. The Cannabis Stock does not recommend selling or buying any of the company mentioned and is not responsible for any losses that may result.